已收盘 05-15 16:00:00 美东时间
-0.020
-1.12%
5月12日消息,国家知识产权局信息显示,南京天纵易康生物科技股份有限公司申请一项名为“一种水溶性超分子三元复合体及其外用制剂、制备方法和应用”的专利。申请公布号...
05-12 09:57
5月8日消息,国家知识产权局信息显示,南京天纵易康生物科技股份有限公司申请一项名为“基于培养基制备的螺旋导流式混合搅拌装置”的专利,授权公告号CN224180...
05-08 11:14
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
eHealth (NASDAQ:EHTH) affirms FY2026 sales outlook from $405.000 million-$445.000 million to $405.000 million-$445.000 million vs $427.675 million estimate.
05-07 04:24
eHealth (NASDAQ:EHTH) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.68) by 14.71 percent. This is a 190 percent decrease over losses of $(0.20) per share from the same
05-07 04:23
eHealth announces annual shareholder meeting via webcast eHealth scheduled 2026 annual shareholder meeting for June 18, 2026 via virtual webcast. Shareholders will vote on election of two Class II directors, including nominees Prama Bhatt and Beth A. Brooke. Ballot also includes ratification of Erns
04-29 08:06
4月25日消息,国家知识产权局信息显示,南京天纵易康生物科技股份有限公司申请一项名为“一种内置换热螺旋管的大肠杆菌恒温发酵装置”的专利,授权公告号CN2241...
04-25 09:59
Novo Nordisk Wegovy secures EMA update for room-temp delivery. Simplifying logistics and lowering costs for EU pharmacies.
04-10 00:55
INDIANAPOLIS, March 31, 2026 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace ("eHealth" or the "Company"), today announced that Andrea Bri...
04-01 04:05
今日重点评级关注:LUCID CAPITAL MARKETS:上调INmune Bio评级至"买入" 目标价从2美元升至9美元;Clear Street:维持MoonLake Immunotherapeutics Class A"买入"评级,目标价从45美元升至70美元
03-12 12:34